Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union
Mol Ther
.
2012 Oct;20(10):1831-2.
doi: 10.1038/mt.2012.194.
Author
Seppo Ylä-Herttuala
PMID:
23023051
PMCID:
PMC3464639
DOI:
10.1038/mt.2012.194
No abstract available
Publication types
Editorial
MeSH terms
Dependovirus*
Drug Approval*
European Union
Genetic Therapy / methods*
Genetic Vectors / standards*
Humans
Hyperlipoproteinemia Type I / therapy*
Legislation, Drug
Lipoprotein Lipase / standards*
Substances
Lipoprotein Lipase